NCATS Seeks New Drug Development Partners and Pharmaceutical Assets

Researcher in lab standing by microscope

NCATS is seeking new drug development partners and pharmaceutical assets to expand its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program. Through this program, NCATS matches researchers with a selection of pharmaceutical industry assets to test ideas for therapeutic uses.

NCATS coordinates the solicitation of ideas from the academic community, conducts NIH peer review of the ideas and funds the Phase II clinical trial of meritorious projects. NCATS’ drug development partners provide their drug or biologic to funded investigators who will explore the compounds to test for potential new uses. The partners also provide documentation so that funded investigators can file or cross-reference an Investigational New Drug application with the Food and Drug Administration.

Potential partners, including companies with at least three assets available that have been in Phase 1 clinical trials, should email NCATS at by June 9, 2016.

Note that while NCATS is not soliciting New Therapeutic Uses applications at this time, more information will be provided late this year.